The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators

Journal of Molecular Biology

Volumn 322, Issue 3, 2002, Pages 559-568

  Somoza, John R ^a   Palmer, James T ^a   Ho, Joseph D ^a  

^a Department of Medicinal and Structural Chemistry ^*  (United States)

Author keywords

Cysteine protease; Drug design; Papain family; Proteinase; Vinyl sulfone

Indexed keywords

CATHEPSIN F; ENZYME INHIBITOR; IMMUNOMODULATING AGENT; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; VINYL SULFONE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME SPECIFICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0036382928     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00780-5     Document Type: Article

References (30)

1. Hiltbold, E. M. & Roche, P. A. (2002). Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 14, 30-35.
2. Driessen, C., Bryant, R. A. R., Lennon-Dumenil, A. M., Villadangos, J. A., Wolf, P. R., Shi, G.-P. et al. (1999). Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 147, 775-790.
3. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J. et al. (1998). Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science, 280, 450-453.
4. Somoza, J. R., Zhan, H., Bowman, K. K., Yu, L., Mortara, K. D., Palmer, J. T. et al. (2000). Crystal structure of human cathepsin V. Biochemistry, 39, 12543-12551.
5. Brömme, D., Li, Z., Barnes, M. & Mehler, E. (1999). Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry, 38, 2377-2385.
6. Shi, G. P., Bryant, R. A., Riese, R., Verhelst, S., Driessen, C., Li, Z. et al. (2000). Role for cathepsin F in invariant chain processing and major histo-compatibility complex class II peptide loading by macrophages. J. Expt. Med. 191, 1177-1186.
7. McGrath, M. E., Klaus, J. L., Barnes, M. G. & Brömme, D. (1997). Crystal structure of human cathepsin K complexed with a potent inhibitor. Nature Struct. Biol. 4, 105-109.
8. Polgar, L. (1974). Mercaptide-imidazolium ion-pair: the reactive nucleophile in papain catalysis. FEBS Letters, 47, 15-18.
9. Lewis, S. D., Johnson, F. A. & Shafer, J. A. (1976). Potentiometric determination of ionizations at the active site of papain. Biochemistry, 15, 5009-5017.
10. 2+ and of methylmercuric iodide to papain. Eur. J. Biochem. 71, 383-391.
11. Turk, D., Podobnik, M., Popovic, T., Katunuma, N., Bode, W., Huber, R. & Turk, V. (1995). Crystal structure of cathepsin B inhibited with CA030 at 2.0 Å resolution: a basis for the design of specific epoxysuccinyl inhibitors. Biochemistry, 34, 4791-4797.
12. Thompson, S. K., Halbert, S. M., DesJarlais, R. L., Tomaszek, T. A., Levy, M. A., Tew, D. G. et al. (1999). Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors. Bioorg. Med. Chem. 7, 599-605.
13. Scheidt, K. A., Roush, W. R., McKerrow, J. H., Selzer, P. M., Hansell, E. & Rosenthal, P. J. (1998). Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. Bioorg. Med. Chem. 6, 2477-2494.
14. Greenspan, P. D., Clark, K. L., Tommasi, R. A., Cowen, S. D., McQuire, L. W., Farley, D. L. et al. (2001). Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. J. Med. Chem. 44, 4524-4534.
15. Nowick, J. S., Powell, N. A., Nguyen, T. M. & Noronba, G. (1992). An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates. J. Org. Chem. 57, 7364-7366.
16. Palmer, J. T., Rasnick, D., Klaus, J. L. & Brömme, D. (1995). Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38, 3193-3196.
17. Otwinowski, Z. & Minor, W. (1993). Data Collecting and Processing Data Collecting and Processing, SERC Daresbury Laboratory, Warrington, UK.
18. Navaza, J. (1994). AmoRe: an automated package for molecular replacement. Acta Crystallog. sect. A, 50, 157-163.
19. Brinen, L. S., Hansell, E., Cheng, J., Roush, W. R., McKerrow, J. H. & Fletterick, R. J. (2000). A target within a target: probing cruzain's P1′ site to define structural determinants for the Chagas' disease protease. Struct. Fold. Des. 8, 831-840.
20. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W. et al. (1998). Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D, 54, 905-921.
21. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26, 283-291.
22. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 4673-4680.
23. Kabsch, W. & Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577-2637.
24. Kraulis, P. J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24, 946-950.
25. Merritt, E. A. & Murphy, M. E. P. (1994). Raster3D, version 2.0. A program for photorealistic molecular graphics. Acta Crystallog. sect. D, 50, 869-873.
26. McGrath, M. E., Palmer, J. T., Brömme, D. & Somoza, J. R. (1998). Crystal structure of human cathepsin S. Protein Sci. 7, 1294-1302.
27. Guncar, G., Podobnik, M., Pungercar, J., Strukelj, B., Turk, V. & Turk, D. (1998). Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure, 6, 51-61.
28. Turk, D., Janjic, V., Stern, I., Podobnik, M., Lamba, D., Dahl, S. W. et al. (2001). Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 20, 6570-6582.
29. Coulombe, R., Li, Y., Takebe, S., Ménard, R., Mason, P., Mort, J. S. & Cygler, M. (1996). Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15, 5492-5503.
30. Guncar, G., Klemencic, I., Turk, B., Turk, V., Karaoglanovic-Carmona, A., Juliano, L. & Turk, D. (2000). Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. Struct. Fold. Des. 8, 305-313.